CAMP: Camp4 Therapeutics Corporation - Summary | Jitta

Camp4 Therapeutics Corporation

NASDAQ:CAMP

Price
$4.46
Loss Chance
54.1%
2.48JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
316 / 718
2,520 / 4,226
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (64)
Financial Strength (32)
Return to Shareholders (0)
Competitive Advantage (41)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Key Stats
Jitta Score
Jitta Line
2.48
100.00%
2.20
144.61%
3.06
136.28%
Biotechnology
5.50
52.11%
1.82
73.65%
1.82
73.65%
COMPANY DESCRIPTION
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.